Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2003; 42:437-445, doi:10.1016/S0735-1097(03)00658-2
© 2003 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leesar, M. A.
Right arrow Articles by Bolli, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leesar, M. A.
Right arrow Articles by Bolli, R.

Nonelectrocardiographic evidence that both ischemic preconditioning and adenosine preconditioning exist in humans

Massoud A. Leesar, MD*, Marcus F. Stoddard, MD*, Yu-Ting Xuan, PhD*, Xian-Liang Tang, MD* and Roberto Bolli, MD*,*

* Division of Cardiology, University of Louisville and Jewish Hospital Heart and Lung Institute, Louisville, Kentucky, USA



View larger version (24K):

[in a new window]
 
Figure 1 ST-segment shift on the intracoronary electrocardiogram (ECG) (top), ST-segment shift on the surface ECG (middle), and chest pain score (bottom) at the end of the first, second, and third balloon inflations in control and adenosine-pretreated patients. Brackets indicate the pairwise comparisons that were performed. Values are means ± SEM.

 


View larger version (32K):

[in a new window]
 
Figure 2 Chordal shortening in the ischemic/reperfused left ventricular (LV) region (upper panel) and Vp (bottom panel) at baseline; at the end of the adenosine infusion; at the end of the first, second, and third balloon inflations (Infl-1, Infl-2, and Infl-3); immediately before the second and third inflations (Pre-Infl-2 and Pre-Infl-3); and 5 min after the third inflation (5' post-Infl-3) in control and adenosine-treated patients. Pairwise comparisons were performed between groups during each inflation and among inflations within each group. Values are means ± SEM.

 


View larger version (22K):

[in a new window]
 
Figure 3 Lactate extraction ratio in the ischemic/reperfused left ventricular region at baseline; immediately after the end of the first, second, and third balloon inflations (Infl-1, Infl-2, and Infl-3); and immediately before the second and third inflations (Pre-Infl-2 and Pre-Infl-3) in control and adenosine-treated patients. Brackets indicate the pairwise comparisons that were performed. Data are means ± SEM.

 


View larger version (25K):

[in a new window]
 
Figure 4 Transcardiac gradient in coronary blood pH at baseline; immediately after the first, second, and third balloon inflations (Infl-1, Infl-2, and Infl-3); and immediately before the second and third inflations (Pre-Infl-2 and Pre-Infl-3) in control and adenosine-treated patients. Because arterial pH did not change significantly, the differences in the gradient indicate changes in great cardiac vein pH. Brackets indicate the pairwise comparisons that were performed. Data are means ± SEM. A-GCV = aorta-great cardiac vein.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement